4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-17-027776
CEO and Director bought 2,552 shares at $3.00 ($7,656)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MENDLEIN JOHN CEO and Director | 2017-04-18 | Purchase | +1,000 | $3.00 | $3,000 | 325,971 | D |
| MENDLEIN JOHN CEO and Director | 2017-04-20 | Purchase | +1,552 | $3.00 | $4,656 | 327,523 | D |
| Open-market purchases · 2,552 sh · avg $3.00 · $7,656 | |||||||
Loading xslF345X03/doc4.xml…